International Scientific Publishing Co.
Advances in Biomedicine and Pharmacy

Ethics Statement

Publication Ethics and Publication Malpractice Statement

Advances in Biomedicine and Pharmacy (An International Journal of Biomedicine, Natural Products and Pharmacy) and its Publisher, International Scientific Publishing Co., are members of Committee on Publication Ethics (COPE). As such, this journal follows Code of Conduct, COPE and Best Practice Guidelines for Journal Editors and the Code for Journal Publishers.
In addition, as a journal that follows the ICMJE’s Recommendations for the Publication, Editing, Reporting and Conduct of Scholarly Work in Medical Journals, it is expected of editors, reviewers and authors that they adopt the best-practice guidelines on principled behaviour contained therein.

For full details you should always consult the three documents listed above, but some of the key points are included below.

Duties of Authors

Reporting Standards

An accurate account of the work performed and the resultsshould be presented by authors of original research, followed by an objective discussion of the implication of the work. Sufficient detail and references should be there in the manuscript to permit others to repeat the work. Review articles should be updated, accurate and objective.Fake or knowingly inaccurate reports constitute unethical behaviour and are not acceptable.

Availability of raw data and retention

For editorial review authors may be asked to furnish the raw data of their research work together along with the manuscript and should be capableof making the data publicly available if needed. In any event, for at least 10 years after publication authors should endorse accessibility of such data to other competent professionals, if possible through an institutional or subject-based data storehouse or other data centre, on condition that that the confidentiality of the participants can be protected and permissible rights regarding proprietary data do not prevent their release.

Originality of the data and plagiarism

It should be ensured byauthors that they have written and submitted only original works, and in case they have used the work and/or words of other authors, then it should be properly cited. Most of those publications should be cited which have put impact in determining the nature of the work. Plagiarism, which may include using another’s paper as the authors own, or copying significant parts of another author’s paper orclaiming results from other author’s research work, is unethical and should be unacceptable.

Multiple, duplicate, redundant or concurrent submission/publication

Papers reporting basically the same research should not be published in more than one journal or other publication. Authors should desist from submitting a manuscript that has formerly been published in another journal. Submission of a manuscript simultaneously to more than one journal is unethical publishing conduct and not acceptable.The publication of some kinds of articles such as translations, clinical guidelines in more than one journal can be justified occasionally, provided that certain rules are followed. Concerned authors and editors of the journals must reach an agreement to the secondary publication, which must exhibit the same data and version of the primarywork.

Duties of Editor

Editorial independence and Confidentiality

The manuscripts are evaluated solely on the basis of scientific merit and scope of the journal irrespective of any bias. Decision to publish are not influenced by any other agency outside the journal itself. Editorial staff will not release any information related to a submitted manuscript to anyone except the corresponding author, reviewers, potential reviewers, other editorial advisers, and the publisher, as suitable.

Conflicts of interest

Editors or other editorial staff should not in any case utilize the information contained in the unpublished submitted manuscript for their own research purposes without the authors written consent. Any information or ideasacquired by editors as a result of manuscript handling will be kept confidential and not used for any personal benefit. Editors will declare in advance and avoid handling manuscripts in which they have conflicts of interest so that the manuscript is handled by other appropriate editorial member.

Publication decisions

The editors will make sure that the manuscripts submitted to the journal undergo peer-review by at least two reviewers professional in the field. The Editor-in-Chief will decide about the publication of the manuscripts submitted to the journal will be published based on several criteria including the validation of the work, importance to researchers and readers and the reviewers’ comments. The Editor-in-Chief may take suggestions from other editors or reviewers in making the final decision.

Cooperation in investigations

In case any ethical concerns are raised with regard to a submitted manuscript and/or published manuscript, editor will take responsive measures in association with the publisher and/or the society. Any reported act of unethical publishing will be looked into even reported years after publication. All editorial members follow the COPEFlowcharts when dealing with cases of suspected misconduct.

Duties of Reviewer

Assisting editorial decision making

Peer review is important assessment of scientific merit of the manuscripts that assists editors in making editorial decisions and help authors in improving their manuscripts. Like several other we strongly believe that all scholars who contribute to the scientific process have aresponsibity to do a fair share of reviewing.

Timeliness and confidentiality

Any invited referee who feels unqualified to review and if prompt review will be impossible should instantly notify the editors and as such decline the invitation to review so that alternative reviewers can be contacted.Any manuscripts submitted to the journal for review are highly confidential documents and must be considered as such and must not be exposed to or discussed with others except if allowed by the Editor-in-Chief (under exceptional and specific circumstances). This is also applicable to invited reviewers who decline the invitation to review.

Objectivity standards

Reviews should be conducted objectively and observations formulated clearly with supporting arguments so that authors can use them for improving the manuscript. Personal criticism of the authors is inappropriate.

Acknowledgement of the original sources

Reviewers should asses the manuscripts carefully and identify if any relevant published information has not been cited by the authors. Any statement that that has been reported in previous publications should be supplemented by the relevant citation. A reviewer should alwaysinform the editors of any significant similarity or overlap between the manuscript under consideration and any other published or unpublishedmanuscript of which they have personal knowledge.

Duties of Publisher

Unethical publishing behaviour

If scientific misconduct, fraud publication or plagiarism is found the publisher will take all suitable measures in collaboration with the editors to illuminate the situation and to correct the article in question. This includes the swift publication of an erratum, explanation or, in the most serious case, the retraction of the published work. The publisher in association with editors shall take reasonable steps to detect and prevent the publication of papers where research misconduct has occurred, and under no conditions encourage such misconduct.

Access to journal articles

The publisher is dedicated to the preservation and permanent availability of scholarly research and ensures availability by partnering with organizations and sustaining our own digital archive. Advances in Biomedicine and Pharmacy is a permanent member of CrossRef, which provides digital archiving for our articles. Digital object identifier (doi) is created for each article published in the journal.